Highbridge Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,068	Closed	-$243K	–	802
2017 Q1	$243K	Buy	+7,068	New	+$243K	﹤0.01%	947
2016 Q2	–	Sell	-31,648	Closed	-$885K	–	1018
2016 Q1	$885K	Buy	+31,648	New	+$885K	0.01%	447